Ted Morton, PharmD, BCIDP

Ted Morton, PharmD, BCIDP

  • Infectious Diseases Pharmacy Residency Director
  • Associate Professor, The University of Tennessee Health Sciences Center, Department of Clinical Pharmacy and Translational Science

Board Certification

  • BCIDP

Education

PharmD – University of Florida, Gainesville, Florida

Post-Graduate Training

  • PGY1 Pharmacy Practice Residency – Regional One Healthcare, Memphis, Tennessee

Focused Area of Practice

  • Antimicrobial Stewardship / Infectious Diseases
  • Clinical Education and Training

Honors/Awards

  • 2020  Clinical Care Improvement Award for Clinical Pharmacy Services, St. Jude Children’s Research Hospital 
  • 2018  Innovative Practice Award (Team Member), Tennessee Society of Health-System Pharmacists
  • 2005  Excellence in Teaching Award, College of Pharmacy – Student Government Association Executive Council of the University of Tennessee Health Science Center
  • 2005  Teacher of the Year Award, P-2 class, University of Tennessee College of Pharmacy
  • 2005  Residents’ Choice Award, University of Tennessee Department of Medicine Residency Program
  • 2004  Preceptor of the Year, University of Tennessee College of Pharmacy
  • 2003  Pharmacist of the Year, Tennessee Society of Health-System Pharmacy

Research Interest

  • Antimicrobial Stewardship

St. Jude Committee Service

  • Antimicrobial Utilization and Improvement Committee
  • Infection Prevention and Control Committee
  • Residency Advisory Committee

Pharmacy Organizations/Committee Service

  • American College of Clinical Pharmacy
  • American Society of Health-System Pharmacists
  • MidSouth College of Clinical Pharmacy
  • Pediatric Infectious Diseases Society
  • Society of Infectious Diseases Pharmacists
  • Tennessee Pharmacists Association and Tennessee Society of Hospital Pharmacists

Selected Publications

Cross SJ, Morton TH, Wolf J.  Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.  J Pediatric Infect Dis Soc. 2021 [in press]

Joshua Wolf, Mark J Abzug, Rachel L Wattier, Paul K Sue, Surabhi B Vora, Philip Zachariah, Daniel E Dulek, Alpana Waghmare, Rosemary Olivero, Kevin J Downes, Scott H James, Swetha G Pinninti, April Yarbrough, Margaret L Aldrich, Christine E MacBrayne, Vijaya L Soma, Steven P Grapentine, Carlos R Oliveira, Molly Hayes, David W Kimberlin, Sarah B Jones, Laura L Bio, Theodore H Morton, Jane S Hankins, Gabriela M Maron, Kathryn Timberlake, Jennifer L Young, Rachel C Orscheln, Hayden T Schwenk, David L Goldman, Helen E Groves, W Charles Huskins, Nipunie S Rajapakse, Gabriella S Lamb, Alison C Tribble, Elizabeth C Lloyd, Adam L Hersh, Emily A Thorell, Adam J Ratner, Kathleen Chiotos, Mari M Nakamura, Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents, Journal of the Pediatric Infectious Diseases Society, Volume 10, Issue 5, May 2021, Pages 629–634, https://doi.org/10.1093/jpids/piaa175

Dove ML, Jaggi P, Kelleman M, Abuali M, Ang JY, Ballan W, Basu SK, Campbell MJ, Chikkabyrappa SM, Choueiter NF, Clouser KN, Corwin D, Edwards A, Gertz SJ, Ghassemzadeh R, Jarrah RJ, Katz SE, Knutson SM, Kuebler JD, Lighter J, Mikesell C, Mongkolrattanothai K, Morton T, Nakra NA, Olivero R, Osborne CM, Panesar LE, Parsons S, Patel RM, Schuette J, Thacker D, Tremoulet AH, Vidwan NK, Oster ME. Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management. J Pediatr. 2021 Feb;229:33-40. doi: 10.1016/j.jpeds.2020.10.026. Epub 2020 Oct 16. PMID: 33075369; PMCID: PMC7566788.

Last update: September 2023

Close
Close